Back to Agenda
Evaluating Potential Contribution of Social Media to Postmarketing Medication Safety Surveillance
Session Chair(s)
Preciosa M. Coloma, MD, PHD, MSC, RPH
Assistant Professor of Pharmacoepidemiology and Medical Informatics, Erasmus MC University Medical Center, Netherlands
Social Media and Pharmacovigilance
Learning Objective : Provide an overview of the potential usefulness of various social media data sources for postmarketing medication safety surveillance; Discuss various approaches to evaluating the potential contribution of social media data sources to postmarketing medication safety surveillance.
Speaker(s)
Stella Stergiopoulos, MPH, MS
Director, Health Economic and Outcomes Research, EQRx, United States
Social Media and Pharmacovigilance
Sally Okun, BSN, MHS, MBA, RN
Executive Director, Clinical Trials Transformation Initiative (CTTI), United States
Evaluating Medication Safety and Effectiveness Using Patient-Generated Data
Michael A. Ibara, PHARMD
Chief Data Officer, Elligo Health Research, United States
Reinventing Safety: What Will It Take to Realize the Promise of Digital Pharmacovigilance and Social Media?
Have an account?